24
Participants
Start Date
March 31, 2011
Primary Completion Date
June 30, 2011
Study Completion Date
June 30, 2011
CKD-501, Ketoconazole
Subjects received single 0.5mg doses of CKD-501 alone in one period and, in the other period, Ketoconazole 200 mg twice daily for 5 day with the CKD-501 dose also co-administered with Ketoconazole on day 5.
Severance Hospital, Seoul
Lead Sponsor
Severance Hospital
OTHER
Chong Kun Dang Pharmaceutical
INDUSTRY